Clinical Trial Update: Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib for newly diagnosed glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED